GENELUX Corp (GNLX) stock
GNLXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 5/30
$2.00+0.08 (+4.17%)
Close on Nov 17, 2026Market cap $90.49MP/E –Yield –
Genelux EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
No ev/ebitda figures for Genelux
Genelux has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?